Wolfe Danielle M, Webster Carrion Andrea, Masukhani Mahesh M, Oberg Jennifer A, Pavisic Jovana, El-Ali Alexander, Gupta Mala, Weng Katherine, Glasser Chana L
Departments of Pediatrics.
Departments of Pediatric Hematology, Oncology, and Stem Cell Transplantation.
J Pediatr Hematol Oncol. 2023 May 1;45(4):e525-e529. doi: 10.1097/MPH.0000000000002593. Epub 2022 Nov 17.
Beckwith-Wiedemann syndrome (BWS) is an epigenetic overgrowth disorder and cancer predisposition syndrome caused by imprinting defects of chromosome 11p15.5-11p15.4. BWS should be considered in children with atypical presentations of embryonal tumors regardless of clinical phenotype. Risk of malignancy correlates with specific molecular subgroups of BWS making molecular subclassification important for appropriate cancer screening. We report the first case of concurrent embryonal tumors in a phenotypically normal child, leading to the diagnosis of BWS with paternal uniparental disomy and describe the molecular classification of BWS as it relates to malignancy risk, along with approach to management.
贝克威思-维德曼综合征(BWS)是一种由11p15.5 - 11p15.4染色体印记缺陷引起的表观遗传过度生长障碍和癌症易感性综合征。对于有胚胎性肿瘤非典型表现的儿童,无论其临床表型如何,均应考虑BWS。恶性肿瘤风险与BWS的特定分子亚组相关,这使得分子亚分类对于适当的癌症筛查很重要。我们报告了首例表型正常儿童并发胚胎性肿瘤的病例,该病例导致了父源单亲二体性BWS的诊断,并描述了与恶性肿瘤风险相关的BWS分子分类以及管理方法。